SCHEMBL3567012

SCHEMBL3567012

CN(C)C(=O)c1cc(Cl)nnc1Cl

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
RAB9A P51151 1/20 0.42
CNR1 P21554 1/20 0.40
PIK3C3 Q8NEB9 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
HPGD P15428 2/20 0.37
HTT P42858 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 1/20 0.36
ALPL P05186 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
CASP1 P29466 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25319161 0.83 OPRK1 (0.43) ALDH1A1CNR1PIK3C3HPGDHTT
SCHEMBL30508857 0.83 OPRK1 (0.43) ALDH1A1CNR1PIK3C3HPGDHTT
SCHEMBL17640648 0.82 ALDH1A1 (0.46) ALDH1A1LMNAL3MBTL1RAB9ATDP1
SCHEMBL3560530 0.81 ALDH1A1 (0.41) ALDH1A1LMNACNR1PIK3C3TDP1
SCHEMBL1189483 0.80 ALDH1A1 (0.44) ALDH1A1LMNAL3MBTL1RAB9ATDP1
SCHEMBL105936 0.78 ALDH1A1 (0.50) ALDH1A1LMNAL3MBTL1RAB9ATDP1
SCHEMBL29412881 0.75 KEAP1 (0.48) ALDH1A1LMNAL3MBTL1RAB9ATDP1
SCHEMBL104396 0.75 KEAP1 (0.48) ALDH1A1LMNAL3MBTL1RAB9ATDP1
SCHEMBL30833982 0.75 ALDH1A1 (0.44) ALDH1A1LMNAL3MBTL1RAB9ATDP1
SCHEMBL354023 0.75 ALDH1A1 (0.44) ALDH1A1LMNAL3MBTL1RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709645-B2 Pyrrolo-pyridine kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-05-04 US disclosed
US-7709645-B2 Pyrrolo-pyridine kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-05-04 US disclosed
US-7709645-B2 Pyrrolo-pyridine kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-05-04 US disclosed
EP-2134343-A2 PYRROLO-PYRIDINE KINASE MODULATORS SGX Pharmaceuticals, Inc. (US) 2009-12-23 EP disclosed
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS SGX PHARMACEUTICALS, INC. (US) 2009-06-04 US disclosed
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS SGX PHARMACEUTICALS, INC. (US) 2009-06-04 US disclosed
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS SGX PHARMACEUTICALS, INC. (US) 2009-06-04 US disclosed
WO-2009050227-A1 PYRIDAZINE DERIVATIVES FOR INHIBITING BETA AMYLOID PEPTIDE PRODUCTION GLAXO GROUP LIMITED (GB) 2009-04-23 WO disclosed
WO-2008124849-A2 PYRROLO-PYRIDINE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2008-10-16 WO disclosed
WO-2008124849-A2 PYRROLO-PYRIDINE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS MAP4K2, PDXK, MAP4K1 ALDH1A1 4246/4885LMNA 3935/4885L3MBTL1 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.